Latest Bavarian Nordic News & Updates

See the latest news and media coverage for Bavarian Nordic. We track all announcements, press releases, and industry mentions in real time, all in one place.

Bavarian Nordic

Biopharmaceutical vaccine company

bavarian-nordic.com

Headquarters: Copenhagen, Denmark
Founded year: 1994
Company type: Public company
Number of employees: 1,700–5,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Bavarian Nordic

In short: Bavarian Nordic reported strong 2025 revenue of DKK 6.2 billion and secured major smallpox/mpox vaccine contracts while evolving its board.

Company announcements

July 13 Bavarian Nordic

Bavarian Nordic partner files for chikungunya vaccine approval in Brazil

Eurofarma submitted the application to Anvisa, marking a milestone in the partnership and a step toward vaccine availability in Brazil.

June 29 Bavarian Nordic

Bavarian Nordic receives Health Canada approval for chikungunya vaccine

The single-dose VLP vaccine VIMKUNYA is approved for individuals 12 years and older, expanding preventive options for travelers.

June 9 Bavarian Nordic

Bavarian Nordic secures a government contract for smallpox/mpox vaccine

Valued over DKK 700 million, deliveries start in 2026 with revenue recognized mainly in 2027.

June 8 Bavarian Nordic

Bavarian Nordic delivers chikungunya vaccine doses to French Guiana

The vaccines will help protect vulnerable communities amid an active outbreak, supporting the public health response.

Media coverage

July 23 AK&M

Nordic Capital and Permira rejected the takeover of Danish Bavarian Nordic for $2.99 billion

A consortium consisting of the Swedish investment company Nordic Capital and the British Permira Holdings Limited refused to take over the Danish biopharmaceutical company Bavarian...

July 13 Euroinvestor

Bavarian Nordic's chikungunya vaccine submitted for regulatory approval in Brazil

COPENHAGEN, Denmark, July 13, 2026 - Bavarian Nordic A/S (OMX: BAVA) announced today that its partner, Eurofarma, has submitted a marketing authorization application to...

June 29 Markets Insider

Bavarian Nordic Receives Health Canada Approval for Chikungunya Vaccine

Bavarian Nordic A/S (OMX: BAVA) today announced that Health Canada has approved VIMKUNYA ® (recombinant, adsorbed) for immunization to prevent disease caused by chikungunya virus...

June 15 The Manila Times

Bavarian Nordic - Transactions in Connection with Share Buy-Back Program | The Manila Times

COPENHAGEN, Denmark, June 15, 2026 - Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on June 2, 2026, under which...

Never miss news about Bavarian Nordic

Track Bavarian Nordic and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Bavarian Nordic competitors & trending companies

Browse news for competitors to Bavarian Nordic and other trending companies.